The present invention relates to the treatment of cancer. More specifically, this invention relates to methods for treating a cancer selected from the group consisting of squamous cell lung cancer, including small cell lung cancer, non-small cell lung cancer, lung adenocarcinoma and squamous cell carcinoma, abdominal cancer, hepatocellular cancer, gastric cancer, including gastrointestinal cancer, pancreatic cancer, glioblastoma, cervical cancer, ovarian cancer, liver cancer, bladder cancer, hepatoma, breast cancer, colon cancer, colorectal cancer CA, endometrial or uterine cancer, salivary carcinoma, kidney or renal cancer, liver cancer, prostate cancer, vaginal cancer, thyroid cancer, liver carcinoma and various types of head and neck cancer, as well as B-cell lymphoma, including follicular non-Hodgkin's lymphoma with a low degree of malignancy (NHL), small cell lymphocytic (SL) NHL, follicular NHL with an intermediate degree of malignancy； diffuse NHL with an intermediate degree of malignancy； high malignant immunoblastoma NHL, high malignant lymphoblastoma NHL, high malignant small non-split cells small volume NHL； lymphomas from cells of the mantle zone, lymphoma associated with HIV infection and Waldenstrom macroglobulinemia； chronic lymphocytic leukemia (CLL), acute lymphoblastoma leukemia (ALL), hair cell leukemia； chronic myeloblastoma leukemia and lymphoproliferative disease after transplantation (PTLD), as well as abnormal vascular proliferation associated with phacomatoses, edema,Настоящее изобретение относится к лечению рака. Более конкретно, это изобретение относится к способам лечения ракового заболевания, выбранного из группы, состоящей из рака сквамозных клеток рака легких, включая мелкоклеточный рак легких, немелкоклеточный рак легких, аденокарциномы легкого и сквамозной карциномы легкого, рака брюшной полости, гепатоцеллюлярного рака, рака желудка, включая рак желудочно-кишечного тракта, рака поджелудочной железы, глиобластомы, рака шейки матки, р
